Michael Bergerhausen

Title: Michael Bergerhausen: Innovator in Antitumoral Arenavirus Research

Introduction

Michael Bergerhausen is a notable inventor based in Duisburg, Germany. He has made significant contributions to the field of medical research, particularly in the development of antitumoral therapies. His innovative work focuses on the creation of mutant arenaviruses with enhanced therapeutic properties.

Latest Patents

Michael holds a patent for a "Method for producing an antitumoral arenavirus as well as arenavirus mutants." This invention pertains to a mutant of an arenavirus that exhibits improved antitumoral properties. The patent also encompasses a method for generating such arenavirus mutants, along with related pharmaceutical compositions, medical uses, methods of treatment, and isolated proteins and nucleic acids. He has 1 patent to his name.

Career Highlights

Michael is currently associated with Abalos Therapeutics GmbH, where he continues to advance his research in the field of virology and oncology. His work is pivotal in exploring new avenues for cancer treatment through innovative viral therapies.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues, including Karl Lang and Cornelia Hardt. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking medical solutions.

Conclusion

Michael Bergerhausen's contributions to the field of antitumoral research exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds the potential to improve treatment options for cancer patients.